Myelopathy

Top Story

Metabolite, functional profile of patients with CSM may be used to discriminate mild, moderate disease

June 30, 2017

Results from this recently published study indicated the N-acetylaspartate to creatine ratio and the volume of activation in the primary motor cortex can be used to differentiate between mild and moderate cervical spondylotic myelopathy.

Researchers identified 28 patients with cervical spondylotic myelopathy who underwent 3-T MRI scans before surgery and at 6 months postoperatively. The modified Japanese Orthopaedic Association questionnaire was used to determine severity of disease. Investigators also performed two MRI scans 6 months apart in 10 healthy control patients. In the patient cohort, investigators measured the metabolite levels from the primary motor cortex (M1) contralateral to the greater deficit side. In the controls, they measured both sides. A right finger-tapping paradigm was used to assess motor function.

In the Journals

Similar clinical outcomes seen with hybrid-CDA, ACDF for patients with congenital cervical stenosis

June 22, 2017
Investigators of this study found in patients with myelopathy due to congenital cervical stenosis, hybrid-cervical disc arthroplasty had similar clinical improvements as…

NASS opens 30-day comment period for new coverage recommendations

April 21, 2017
The North American Spine Society has opened a 30-day public comment period for the recently developed draft coverage recommendations on allograft and demineralized bone…
In the Journals

Study cites factors predictive of surgical approach for cervical spondylotic myelopathy

April 20, 2017
Investigators of this study of national data found non-white race and non-private insurance were predictive factors for posterior-only cervical spondylotic myelopathy…
More Headlines »
Advertisement
Advertisement